Ainos (AIMD) Competitors

$1.04
0.00 (0.00%)
(As of 04/26/2024 ET)

AIMD vs. SHPH, KZIA, IBIO, HILS, YMTX, VCNX, FWBI, CLVR, KA, and ENVB

Should you be buying Ainos stock or one of its competitors? The main competitors of Ainos include Shuttle Pharmaceuticals (SHPH), Kazia Therapeutics (KZIA), iBio (IBIO), Hillstream BioPharma (HILS), Yumanity Therapeutics (YMTX), Vaccinex (VCNX), First Wave BioPharma (FWBI), Clever Leaves (CLVR), Kineta (KA), and Enveric Biosciences (ENVB). These companies are all part of the "pharmaceutical preparations" industry.

Ainos vs.

Shuttle Pharmaceuticals (NASDAQ:SHPH) and Ainos (NASDAQ:AIMD) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, community ranking, dividends, institutional ownership, valuation, earnings, risk, analyst recommendations and media sentiment.

Shuttle Pharmaceuticals has a net margin of 0.00% compared to Shuttle Pharmaceuticals' net margin of -11,205.49%. Shuttle Pharmaceuticals' return on equity of -47.96% beat Ainos' return on equity.

Company Net Margins Return on Equity Return on Assets
Shuttle PharmaceuticalsN/A -112.18% -80.89%
Ainos -11,205.49%-47.96%-40.37%

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Shuttle Pharmaceuticals
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
Ainos
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

4.6% of Shuttle Pharmaceuticals shares are held by institutional investors. 40.6% of Shuttle Pharmaceuticals shares are held by insiders. Comparatively, 4.6% of Ainos shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Shuttle Pharmaceuticals has higher earnings, but lower revenue than Ainos. Shuttle Pharmaceuticals is trading at a lower price-to-earnings ratio than Ainos, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Shuttle PharmaceuticalsN/AN/A-$6.59M-$0.43-0.90
Ainos$120K53.22-$13.77M-$2.55-0.41

In the previous week, Shuttle Pharmaceuticals had 1 more articles in the media than Ainos. MarketBeat recorded 2 mentions for Shuttle Pharmaceuticals and 1 mentions for Ainos. Shuttle Pharmaceuticals' average media sentiment score of 1.00 beat Ainos' score of 0.00 indicating that Ainos is being referred to more favorably in the news media.

Company Overall Sentiment
Shuttle Pharmaceuticals Neutral
Ainos Positive

Shuttle Pharmaceuticals and Ainos both received 0 outperform votes by MarketBeat users.

CompanyUnderperformOutperform
Shuttle PharmaceuticalsN/AN/A
AinosN/AN/A

Shuttle Pharmaceuticals has a beta of -1.13, indicating that its share price is 213% less volatile than the S&P 500. Comparatively, Ainos has a beta of 1.44, indicating that its share price is 44% more volatile than the S&P 500.

Summary

Shuttle Pharmaceuticals and Ainos tied by winning 6 of the 12 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding AIMD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

AIMD vs. The Competition

MetricAinosPharmaceutical IndustryMedical SectorNASDAQ Exchange
Market Cap$6.39M$6.35B$4.95B$7.64B
Dividend YieldN/A3.09%2.92%3.94%
P/E Ratio-0.418.96145.6514.96
Price / Sales53.22299.752,368.1885.79
Price / CashN/A29.9848.1935.33
Price / Book0.205.484.624.26
Net Income-$13.77M$135.59M$103.92M$214.06M
7 Day Performance0.98%0.68%0.74%1.88%
1 Month Performance-8.76%-11.74%-8.16%-5.70%
1 Year PerformanceN/A-4.59%3.70%6.72%

Ainos Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SHPH
Shuttle Pharmaceuticals
0 of 5 stars
$0.39
flat
N/A-76.2%$6.54MN/A-0.908News Coverage
Gap Down
KZIA
Kazia Therapeutics
0 of 5 stars
$0.39
-2.5%
N/A-72.8%$6.36M$20,000.000.002,021Short Interest ↓
Negative News
Gap Down
IBIO
iBio
0 of 5 stars
$1.89
-0.5%
N/AN/A$6.58M$2.38M0.0026Gap Down
HILS
Hillstream BioPharma
0 of 5 stars
$0.38
+2.7%
N/A-66.1%$6.67MN/A-0.531Gap Up
YMTX
Yumanity Therapeutics
0 of 5 stars
$0.62
-7.5%
N/A-84.2%$6.73M$4.84M-0.2140Gap Down
VCNX
Vaccinex
0.2738 of 5 stars
$5.01
+0.8%
N/A-91.9%$6.16M$570,000.00-0.0538Short Interest ↑
News Coverage
Positive News
Gap Down
FWBI
First Wave BioPharma
1.9224 of 5 stars
$3.02
-3.2%
$118.00
+3,807.3%
-95.2%$6.13MN/A-0.019Short Interest ↓
News Coverage
CLVR
Clever Leaves
0 of 5 stars
$3.88
flat
N/A-52.7%$6.79M$17.42M-0.34296Short Interest ↓
News Coverage
Gap Up
KA
Kineta
2.0547 of 5 stars
$0.62
-7.5%
$8.00
+1,190.3%
-84.5%$6.80M$5.44M-0.4511Short Interest ↑
News Coverage
Gap Up
ENVB
Enveric Biosciences
2.3795 of 5 stars
$0.93
+4.5%
$10.00
+970.7%
-49.6%$6.81MN/A-0.127Short Interest ↓
News Coverage
Positive News

Related Companies and Tools

This page (NASDAQ:AIMD) was last updated on 4/28/2024 by MarketBeat.com Staff

From Our Partners